Cargando…

Induction of systemic and therapeutic antitumor immunity using intratumoral injection of bone-marrow derived dendritic cells genetically modified to express interleukin 12 combined with anti-CTLA-4 antibody

Detalles Bibliográficos
Autores principales: Sato-Matsushita, Marimo, Hayakawa, Yoshihiro, Asami, Asuka, Nakayama, Setsuko, Tahara, Hideaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649301/
http://dx.doi.org/10.1186/2051-1426-3-S2-P243
_version_ 1782401328227549184
author Sato-Matsushita, Marimo
Hayakawa, Yoshihiro
Asami, Asuka
Nakayama, Setsuko
Tahara, Hideaki
author_facet Sato-Matsushita, Marimo
Hayakawa, Yoshihiro
Asami, Asuka
Nakayama, Setsuko
Tahara, Hideaki
author_sort Sato-Matsushita, Marimo
collection PubMed
description
format Online
Article
Text
id pubmed-4649301
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46493012015-11-24 Induction of systemic and therapeutic antitumor immunity using intratumoral injection of bone-marrow derived dendritic cells genetically modified to express interleukin 12 combined with anti-CTLA-4 antibody Sato-Matsushita, Marimo Hayakawa, Yoshihiro Asami, Asuka Nakayama, Setsuko Tahara, Hideaki J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4649301/ http://dx.doi.org/10.1186/2051-1426-3-S2-P243 Text en Copyright © 2015 Sato-Matsushita et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Sato-Matsushita, Marimo
Hayakawa, Yoshihiro
Asami, Asuka
Nakayama, Setsuko
Tahara, Hideaki
Induction of systemic and therapeutic antitumor immunity using intratumoral injection of bone-marrow derived dendritic cells genetically modified to express interleukin 12 combined with anti-CTLA-4 antibody
title Induction of systemic and therapeutic antitumor immunity using intratumoral injection of bone-marrow derived dendritic cells genetically modified to express interleukin 12 combined with anti-CTLA-4 antibody
title_full Induction of systemic and therapeutic antitumor immunity using intratumoral injection of bone-marrow derived dendritic cells genetically modified to express interleukin 12 combined with anti-CTLA-4 antibody
title_fullStr Induction of systemic and therapeutic antitumor immunity using intratumoral injection of bone-marrow derived dendritic cells genetically modified to express interleukin 12 combined with anti-CTLA-4 antibody
title_full_unstemmed Induction of systemic and therapeutic antitumor immunity using intratumoral injection of bone-marrow derived dendritic cells genetically modified to express interleukin 12 combined with anti-CTLA-4 antibody
title_short Induction of systemic and therapeutic antitumor immunity using intratumoral injection of bone-marrow derived dendritic cells genetically modified to express interleukin 12 combined with anti-CTLA-4 antibody
title_sort induction of systemic and therapeutic antitumor immunity using intratumoral injection of bone-marrow derived dendritic cells genetically modified to express interleukin 12 combined with anti-ctla-4 antibody
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649301/
http://dx.doi.org/10.1186/2051-1426-3-S2-P243
work_keys_str_mv AT satomatsushitamarimo inductionofsystemicandtherapeuticantitumorimmunityusingintratumoralinjectionofbonemarrowderiveddendriticcellsgeneticallymodifiedtoexpressinterleukin12combinedwithantictla4antibody
AT hayakawayoshihiro inductionofsystemicandtherapeuticantitumorimmunityusingintratumoralinjectionofbonemarrowderiveddendriticcellsgeneticallymodifiedtoexpressinterleukin12combinedwithantictla4antibody
AT asamiasuka inductionofsystemicandtherapeuticantitumorimmunityusingintratumoralinjectionofbonemarrowderiveddendriticcellsgeneticallymodifiedtoexpressinterleukin12combinedwithantictla4antibody
AT nakayamasetsuko inductionofsystemicandtherapeuticantitumorimmunityusingintratumoralinjectionofbonemarrowderiveddendriticcellsgeneticallymodifiedtoexpressinterleukin12combinedwithantictla4antibody
AT taharahideaki inductionofsystemicandtherapeuticantitumorimmunityusingintratumoralinjectionofbonemarrowderiveddendriticcellsgeneticallymodifiedtoexpressinterleukin12combinedwithantictla4antibody